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Malaria parasites within red blood cells digest host hemoglobin into a hydrophobic heme 
polymer, known as hemozoin (HZ), which is subsequently released into the blood stream and 
then captured by and concentrated in the reticulo-endothelial system. Accumulating 
evidence suggests that HZ is immunologically active, but the molecular mechanism(s) 
through which HZ modulates the innate immune system has not been elucidated. This work 
demonstrates that HZ purified from 
 
Plasmodium falciparum
 
 is a novel non-DNA ligand for 
Toll-like receptor (TLR)9. HZ activated innate immune responses in vivo and in vitro, 
resulting in the production of cytokines, chemokines, and up-regulation of costimulatory 
molecules. Such responses were severely impaired in TLR9
 
    
 
and myeloid differentiation 
factor 88 (MyD88)
 
   
 
,
 
 
 
but not in TLR2, TLR4, TLR7, or Toll/interleukin 1 receptor domain–
containing adaptor-inducing interferon 
 
 
 
    
 
mice. Synthetic HZ, which is free of the other 
contaminants, also activated innate immune responses in vivo in a TLR9-dependent manner. 
Chloroquine (CQ), an antimalarial drug, abrogated HZ-induced cytokine production. These 
data suggest that TLR9-mediated, MyD88-dependent, and CQ-sensitive innate immune 
activation by HZ may play an important role in malaria parasite–host interactions.
 
Malaria infection is still the major cause of dis-
ease and mortality in humans, especially in the
tropical regions of the world. Due to a com-
plex life cycle and rapid polymorphism of par-
asite antigens, host–parasite interactions and
resulting innate immune responses to malaria
parasites are still poorly understood despite the
urgent necessity of effective immunotherapeu-
tic interventions (1, 2). Robust innate immune
activation, including proinflammatory cyto-
kine production in response to malaria para-
sites and/or their metabolites released from
ruptured infected red blood cells, has been
linked to the major symptoms such as high
fever (3). Recent evidence suggests that Toll-
like receptors (TLRs) are involved in the innate
immune responses to a variety of pathogens,
including 
 
Plasmodium
 
 (4, 5). In murine malaria
infection, myeloid differentiation factor 88
(MyD88), an essential adaptor molecule for cyto-
kine induction through TLRs, was shown to
be critical for IL-12 induction by 
 
Plasmodium
berghei
 
 parasites that cause liver injury (6). A
recent study has shown that 
 
Plasmodium falci-
parum
 
 blood-stage parasites activate human
plasmacytoid DCs as well as murine DCs
through MyD88- and TLR9-dependent path-
ways, whereas the responsible molecule(s) is
yet unidentified (7).
Hemozoin (HZ), known as a malaria pig-
ment, is a detoxification product of heme mol-
ecules persisting in the food vacuoles of 
 
Plas-
modium
 
 parasite (8, 9). Intracellular HZ is
released into the circulation during schizont
rupture and phagocytosed by myeloid cells,
which results in the concentration of HZ in
the reticulo-endothelial system (9). It has been
shown that HZ purified from 
 
P. falciparum
 
 acti-
vates  macrophages to produce proinflamma-
tory cytokines, chemokines, and nitric oxide
and enhances human myeloid DC maturation
(10, 11). These studies prompted us to study
 
C. Coban and K.J. Ishii contributed equally to this work.
 
CORRESPONDENCE
Shizuo Akira: 
sakira@biken.osaka-u.ac.jp 
IDENTIFICATION OF A NON-DNA LIGAND FOR TLR9 | Coban et al.
 
20
 
the molecular mechanism(s) through which HZ activates the
innate immune system, which may improve our understand-
ing of malaria parasite–host interactions. We found that both
in vivo and in vitro, HZ purified from 
 
P. falciparum
 
 activates
murine immune cells that are mediated by TLR9 and de-
pendent on MyD88. Importantly, such activation was inhib-
ited by chloroquine (CQ), a common antimalarial drug.
 
RESULTS AND DISCUSSION
Purified HZ from 
 
P. falciparum
 
 activates murine spleen and 
DCs through MyD88-dependent pathway
 
To examine whether HZ purified from 
 
P. falciparum
 
 acti-
vates the murine immune system, spleen cells and DCs were
stimulated in vitro with purified HZ, and proinflammatory
cytokine production in the culture supernatant was mea-
sured by ELISA. Flt3 ligand–induced bone marrow–derived
DCs (FL-DCs) produced large amounts of TNF
 
 
 
, IL-
12p40, monocyte chemoattractant protein (MCP)-1, and
IL-6 in response to HZ in a dose-dependent manner to a
similar extent to that of CpG oligodeoxynucleotide (ODN;
Fig. 1 a). To investigate possible roles of TLRs in HZ-
induced innate immune activation, mice lacking MyD88, an
essential adaptor molecule for cytokine inductions mediated
by most TLRs, were used (5). FL-DCs from MyD88
 
   
 
mice showed severely impaired levels of TNF
 
 
 
, IL-12p40,
MCP-1, and IL-6 production upon stimulation with HZ
(Fig. 1 b). Similarly, MyD88
 
    
 
spleen cells showed impaired
responses to produce MCP-1, IL-6, TNF
 
 
 
, IL-12p40, and
IFN-inducible protein 10 in response to HZ (Fig. 1 c and
not depicted). Additionally, HZ stimulated both CD11c
 
 
Figure 1. Purified HZ from P. falciparum activates proinflammatory 
responses through MyD88-dependent pathway. (a) FL-DCs from wild-
type (WT) mice were stimulated with 30 and 100  M of purified HZ for 
24 h. ELISA was performed to measure TNF , IL-12p40, MCP-1, or IL-6 
production in the supernatants. As a control, 3  M CpG DNA (D35) was 
used. (b) FL-DCs and (c) spleen cells from wild-type (solid bars) and MyD88    
mice (open bars) were stimulated with 30  M HZ and 3  M CpG DNA 
(D35) or 100 ng/ml LPS for 24 h. Production of TNF , IL-12p40, MCP-1, and 
IL-6 was measured by ELISA in the culture supernatant. (d) The myeloid DC 
(CD11c  B220 ) and plasmacytoid DCs (CD11c  B220 ) were analyzed for 
CD40 and CD86 expression by flow cytometry. The shaded area represents 
nonstimulated cells, and the solid line represents stimulated cells with HZ. 
Results represent the mean   SD of duplicate cultures and are represen-
tative of at least five independent experiments. n.d., not detected. 
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B220
 
  
 
plasmacytoid and CD11c
 
  
 
B220
 
  
 
myeloid DC sub-
sets of FL-DCs to up-regulate the expression of CD40 and
CD86, which were abrogated in both FL-DC subsets in
MyD88
 
    
 
mice (Fig. 1 d).
 
HZ activation of innate immune responses is Toll/IL-1 
receptor domain–containing adaptor-inducing IFN
 
  
 
(TRIF) 
independent
 
To confirm that HZ-induced innate immune activation is
solely dependent on MyD88, mice lacking TRIF, an essen-
tial adaptor molecule for the MyD88-independent pathway,
were used (5). In contrast to MyD88
 
    
 
mice, FL-DCs from
TRIF
 
    
 
mice responded to HZ and produced TNF
 
  
 
and
IL-12p40 (P 
 
  
 
0.05, TRIF
 
    
 
vs. media) comparable to that
of wild-type mice (P 
 
  
 
0.05; Fig. 2). LPS-induced TNF
 
 
 
and IL-12p40 was impaired in TRIF
 
    
 
FL-DCs, suggesting
that extensively purified HZ from 
 
P. falciparum
 
 cultures is
not contaminated with LPS. These data clearly demonstrate
that HZ activates a proinflammatory response in mice via
MyD88, indicating that one of the MyD88-dependent
TLRs might be involved in the recognition of HZ.
 
HZ activation of innate immune responses is TLR9-dependent
 
Further experiments were performed using spleen cells and
DCs obtained from TLR2
 
   
 
, TLR4
 
   
 
, TLR7
 
   
 
, or
TLR9
 
    
 
mice to examine whether HZ-induced innate im-
mune activations are impaired or altered. HZ stimulated FL-
DCs in wild-type, TLR2
 
   
 
, TLR4
 
   
 
, and TLR7
 
    
 
mice
to up-regulate CD40 and CD86 in both CD11c
 
  
 
B220
 
 
 
plasmacytoid and CD11c
 
  
 
B220
 
  
 
myeloid DC subsets (Fig.
3 a). In contrast, both subsets of FL-DCs derived from
TLR9
 
    
 
mice failed to up-regulate CD40 and CD86 in re-
sponse to HZ (Fig. 3 a). Similarly, FL-DCs derived from
wild-type, TLR2
 
   
 
, TLR4
 
   
 
, and TRL7
 
    
 
mice, but not
from TLR9
 
    
 
mice, produced TNF
 
 
 
, IL-12p40, MCP-1,
and IL-6 in response to HZ (Fig. 3 b and not depicted). It is
of note that HZ did not induce IFN
 
  
 
by FL-DCs, suggest-
ing that the HZ-induced cytokine profile is similar to that of
the K-type CpG ODN (also known as B type), but distinct
from that of the D-type ODN (also know as A-type) or
Figure 2. HZ-induced DC activation is TRIF independent. FL-DCs 
from wild-type (WT) and TRIF    mice were incubated with 30  M HZ and 
100 ng/ml LPS for 24 h, after which supernatants were assayed by ELISA 
for TNF  or IL-12p40 production. Results are the mean   SEM of four 
independent experiments (n   4 mice). P   0.05, HZ (WT) versus HZ 
(TRIF   ). n.d., not detected.
Figure 3. TLR9 mediates HZ-induced innate immune activation. 
(a) The myeloid (CD11c  B220 ) and plasmacytoid DCs (CD11c  B220 ) 
from wild-type (WT) and TLR2   , TLR4   , TLR7   , or TLR9    mice were 
analyzed for CD40 and CD86 expression by flow cytometry. The shaded 
area represents nonstimulated cells, and the solid line represents stimu-
lated cells with HZ. Wild-type and TLR9    cells were incubated with the 
indicated stimuli and analyzed for (b) TNF , IL-12p40, MCP-1, or IL-6 
production by spleen cells and (c) IFN  production by FL-DCs by ELISA. 
Results are representative of at least five independent experiments. n.d., 
not detected. 
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known natural DNA ligands for TLR9 such as bacterial or
viral DNA (Fig. 3 c; reference 12). Nevertheless, these data
clearly demonstrate that TLR9 and MyD88 are critical for
HZ-induced activation of murine spleen cells and DCs.
 
HZ activation of proinflammatory cytokines is MyD88/TLR9 
dependent in vivo
 
To further confirm that HZ activation is mediated by TLR9
and dependent on MyD88 in vivo, purified 
 
P. falciparum
 
 HZ
was injected i.p. into wild-type and MyD88
 
    
 
or TLR9
 
   
 
mice, and serum cytokine productions were monitored. HZ
injection significantly increased serum levels of MCP-1 and
IL-6 in wild-type mice, which peaked between 1 and 4 h
and declined within 6 h (Fig. 4 a). In contrast, such increases
were completely abrogated in MyD88
 
    
 
and TLR9
 
   
 
mice. After 6 h, the cytokine levels declined in wild-type
mice. These data clearly demonstrate that HZ-induced
proinflammatory responses were mediated by TLR9 and
MyD88 both in vitro and in vivo.
Synthetic HZ (
 
 
 
-hematin, synthesized from monomeric
heme in laboratory conditions) is structurally similar to HZ
formed naturally by parasites (13, 14) and free of contami-
Figure 4. Serum cytokine productions by HZ and synthetic HZ 
( -hematin) in vivo are dependent on MyD88 and TLR9. MyD88   , 
TLR9   , or wild-type (WT) mice were injected i.p. with either 1,500  g of 
(a) purified P. falciparum HZ or (b) synthetic HZ (sHZ). Serum levels of 
MCP-1 and IL-6 were measured by ELISA at the indicated time points.
Figure 5. HZ is free of DNA, and HZ-induced proinflammatory cyto-
kine production is DNase and heat resistant, but CQ sensitive. (a) HZ 
was run on an agarose gel and ethidium bromide stained to detect possible 
DNA contamination. M, marker; lane 1, HZ solution (1 mM, 5  l); lane 2, 
heat-inactivated HZ (1 mM, 5  l); lane 3, DNase-treated HZ (1 mM, 5  l); 
lane 4, P. falciparum crude extract (5  l from packed 100 ml of culture 
containing 4.5% parasitemia); lane 5, DNase-treated crude extract (5  l). 
(b) FL-DCs from C57/B6 mice was incubated with either 30  M HZ or with 
DNase treatment, heat inactivation, and/or 10  M CQ for 24 h. Superna-
tants were then collected and measured for TNF  or IL-12p40 by ELISA. As 
a control, 3  M CpG ODN (D35) was used. The value of TNF  by D35 is 
shown. Results are representative of one of three independent experiments 
performed in duplicate (mean   SD). *, P   0.05, HZ versus HZ plus CQ; 
**, P   0.05, CpG ODN versus CpG ODN plus CQ. n.d., not detected.JEM VOL. 201, January 3, 2005 23
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nant derived from parasites or culture. To examine whether
synthetic HZ also activates the innate immune system in a
TLR9-dependent manner, wild-type or TLR9     mice
were injected with synthetic HZ, and then IL-6 and MCP-1
production in sera was monitored. Synthetic HZ injection
into wild-type mice resulted in the production of MCP-1
and IL-6 in serum peaked at 4 h (Fig. 4 b). In contrast, such
responses were abrogated in TLR9    mice (Fig. 4 b). These
data suggest that synthetic HZ as well as natural HZ purified
from P. falciparum stimulates the innate immune system in
mice, excluding the contribution of the other possible con-
taminant(s) to HZ-induced, TLR9-mediated innate immune
activation.
To further exclude any possible contaminants in or dur-
ing HZ preparation from the P. falciparum culture, a series of
analyses was also performed to determine the purity of HZ
in addition to the extensive purification method described
above (11). DNA or RNA was not detectable in HZ or
DNase-treated HZ solution (1 mM) by either ethidium bro-
mide–stained agarose gel (Fig. 5 a) or with a spectrophotom-
eter. DNase treatment or heat inactivation had no effect on
HZ-induced DC production of TNF  and IL-12p40 (Fig. 5
b). Furthermore, genomic DNA and RNA isolated from P.
falciparum did not activate innate immune responses signifi-
cantly, including the production of TNF  and IL-12 (un-
published data and reference 15). No protein or lipid was
detected in the HZ solution (1 mM) by all of the methods
we tested. Taken together, these data strongly suggest that
HZ-induced, TLR9-mediated innate immune activation is
not due to the other contaminants.
HZ-induced innate immune activation is CQ sensitive
The antimalarial drug CQ has been shown to inhibit proin-
flammatory responses during malaria infection in addition to
endo/lysosomal maturations and malaria HZ crystal forma-
tions, whereas the exact mechanism of the antimalarial effects
of CQ is still under debate (8, 16). Recent evidence suggests
that CQ also inhibits TLR9-mediated innate immune activa-
tion (17). To examine the effect of CQ on the HZ-induced
proinflammatory responses, FL-DCs were stimulated with
HZ in the presence of CQ. HZ-induced TNF  and IL-
12p40 productions were diminished by CQ (Fig. 5 b), sug-
gesting that in addition to previously known mechanisms of
CQ inhibition of malaria pathogenesis, CQ may also inhibit
HZ-induced, TLR9-mediated innate immune responses dur-
ing malaria infection, possibly contributing to its therapeutic
effects. Although further studies are needed, it is possible that
in addition to its ability to inhibit HZ formation, CQ may
also interfere with the interaction of HZ with TLR9 or in-
hibit the maturation of HZ-containing phagosome, thereby
inhibiting the following innate immune activation.
It has been shown that TLR9 recognizes CpG motifs in
microbial DNA or self-DNA–chromatin complex with spe-
cific IgG, whereas a non-DNA molecule(s) as a TLR9 ligand
has not been reported (18, 19). This work provides the first
evidence of a non-DNA ligand as recognized by TLR9. HZ
is a crystal form of polymerized heme (ferriprotoporphyrin
IX) produced in the food vacuole of parasites during degra-
dation of hemoglobin from red blood cells. Once captured
by phagocytes such as macrophages and DCs, HZ accumu-
lates in the phagosome where TLR9 can be recruited from
the endoplasmic reticulum via PI3 kinases (20, 21), indicat-
ing that TLR9 may recognize HZ in phagosome. HZ is also
extremely hydrophobic, which may contribute to its immu-
nostimulatory effect according to the hypothesis proposed
recently (22). It is of interest that HZ is originally derived
from hemoglobin in the host red blood cells, but modified
by parasites from free heme (toxic to parasite) into HZ (non-
toxic to parasite), self-molecules (heme) become active “non-
self” molecules in the innate immune system during malaria
infection.
The physiological role of HZ-induced, TLR9-mediated
innate immune activation in malaria infection and the host
defense against it is currently under investigation. Prelimi-
nary results suggest that innate immune responses to malaria
parasite are dependent on multiple factors in the host, in-
cluding TLRs as well as Plasmodium. In particular, it is im-
portant to study whether TLR-mediated innate immune
activation during malaria infection contributes to host-pro-
tective immunity or to malarial immune escape mechanism.
It is of our interest as well to study the molecular mecha-
nisms by which TLR9 discriminates between CpG DNA
and HZ. Nonetheless, these findings clearly demonstrate that
HZ, heme metabolite during malaria infection, activates the
innate immune system via a TLR9-mediated, MyD88-
dependent, and CQ-sensitive pathway, which may open a
key to further understanding of malaria parasite–host interac-
tions in innate immunity.
MATERIALS AND METHODS
Mice. Mutant mice (MyD88-, TRIF-, TLR2-, TLR4-, TLR7-, and
TLR9-deficient) either on a 129/Ola    C57/BL6 or C57/BL6 back-
ground were generated as described previously (23–27). Age-matched
groups of wild-type and mutant mice were used for the experiments. For
the in vivo studies, 1,500  g HZ purified from P. falciparum culture and
synthetic HZ ( -hematin) were injected i.p. (28) into wild-type, MyD88   
or TLR9    mice. Serum was collected from tails at 1, 2, 4, and 6 h for the
cytokine ELISA.
Reagents. Synthetic CpG ODNs D35 (29) were synthesized and pur-
chased from Hokkaido System Science. LPS from Salmonella minnesota Re-
595, hemin chloride, and CQ was purchased from Sigma-Aldrich. DNase
(DNase-I) was purchased from Invitrogen.
Preparation of HZ and synthetic HZ ( -hematin). HZ (nonsoluble
crystalloid structure) was purified from P. falciparum (3D7 strain)–infected
erythrocytes as described previously (11, 13, 14). In brief, after saponin lysis
of erythrocytes, parasites were sonicated and washed seven to eight times in
2% SDS. The pellet was incubated with 2 mg/ml proteinase-K at 37 C
overnight. The pellet was then washed three times in 2% SDS and incu-
bated in 6 M urea for 3 h at room temperature on a shaker. After three to
five washes in 2% SDS and then in distilled water, the HZ pellet was resus-
pended in distilled water and sonicated again before use. In some experi-
ments, HZ was either heat inactivated at 95 C for 15 min or treated with
100 U/ml DNase-I for 1 h as described previously (30). DNase-I treatmentIDENTIFICATION OF A NON-DNA LIGAND FOR TLR9 | Coban et al. 24
was successful in removing genomic DNA completely from the P. falci-
parum crude extract (Fig. 5 a). Quantification of nucleic acid and protein
was performed by using a spectrophotometer or by ethidium bromide stain-
ing in agarose gel, BCA (Bio-Rad Laboratories), or the pyrogallol red
method (Wako Pure Chemical Industries, Ltd.). Total lipid was measured
by TLC using the Bligh-Dyer method (Toray Research Center) or by an
enzymatic method using the Iatron LQ (Mitsubishi Kagaku Iatron Inc.).
Synthetic HZ ( -hematin) was purified from hemin chloride using the pro-
tocol of Jaramillo et al. (28) based on the acetic acid treatment and alkaline
bicarbonate wash. To avoid endotoxin contaminations, all solutions were
prepared using endotoxin-free PBS or distilled water. Endotoxin levels
measured by LAL assays (Bio-Whittaker) were  0.001 EU for each nmole
HZ used.
Quantification of HZ or synthetic HZ ( -hematin). The concentra-
tion of HZ or synthetic HZ was determined by depolymerizing heme poly-
mers in 20 mM sodium hydroxide/2% SDS solution for 2 h at room tem-
perature, and then the OD was read at 400 nm (14). The molar extinction
coefficient for heme is 105 at 400 nm and 25  g P. falciparum HZ equals 29
nmole of heme content (14, 28).
Cells. Single cell suspensions of spleen cells (5   105 cells/well) were cul-
tured in complete RPMI 1640 medium supplemented with 10% FCS for
48 h. FL-DCs (105 cells/well) were generated by culturing bone marrow
cells with Flt3-ligand (100 ng/ml; PeproTech) for 8–9 d in DMEM me-
dium containing 10% FCS. Cells were stimulated in the presence of the
indicated stimuli and supernatants were collected for cytokine ELISA.
Cytokine ELISA. Mouse TNF , IL-12p40, MCP-1, IL-6 (R&D Sys-
tems), and IFN  (PBL Biomedical Laboratories) were measured either from
the supernatants or the serum by ELISA according to the manufacturer’s
instructions.
Flow cytometric analysis of costimulatory molecule expressions.
Cell surface molecule expression of stimulated cells was measured as de-
scribed previously (21). In brief, stimulated cells were washed with ice cold
PBS, fixed, and stained with FITC-, PE-, CyChrome-, and APC-labeled
antibodies in the presence of anti-CD16 antibody for 30 min at room tem-
perature. Stained cells were washed, resuspended in PBS/0.1% BSA/0.1%
NaN3, and analyzed by FACSCalibur followed by analysis using CELLQuest
software (Becton Dickinson). All antibodies were obtained from Becton
Dickinson.
Statistical analysis. Statistically significant differences were analyzed by
using Student’s t test. P   0.05 was considered significant.
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